These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38820023)

  • 21. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
    Oosterhuis I; van Hunsel FP; van Puijenbroek EP
    Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.
    Shrestha S; Sharma S; Bhasima R; Kunwor P; Adhikari B; Sapkota B
    BMC Med Educ; 2020 Jun; 20(1):179. PubMed ID: 32493307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study.
    Shkreli R; Dhamo K; Haloçi E; Tabaku A
    Pak J Pharm Sci; 2023 May; 36(3):713-721. PubMed ID: 37580918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
    O'Callaghan J; Griffin BT; Morris JM; Bermingham M
    BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
    Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
    PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
    Danekhu K; Shrestha S; Aryal S; Shankar PR
    Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
    Khan Z; Karatas Y; Hamid SM
    PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.
    Haines HM; Meyer JC; Summers RS; Godman BB
    Eur J Clin Pharmacol; 2020 Jul; 76(7):991-1001. PubMed ID: 32296857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.
    Cervantes-Arellano MJ; Castelán-Martínez OD; Marín-Campos Y; Chávez-Pacheco JL; Morales-Ríos O; Ubaldo-Reyes LM
    Daru; 2024 Jun; 32(1):421-434. PubMed ID: 38427161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists.
    Lemay J; Alsaleh FM; Al-Buresli L; Al-Mutairi M; Abahussain EA; Bayoud T
    Med Princ Pract; 2018; 27(1):30-38. PubMed ID: 29402876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.
    Salehi T; Seyedfatemi N; Mirzaee MS; Maleki M; Mardani A
    Biomed Res Int; 2021; 2021():6630404. PubMed ID: 33937402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria.
    Adegbuyi TA; Fadare JO; Araromi EJ; Sijuade AO; Bankole I; Fasuba IK; Alabi RA
    Hosp Pharm; 2021 Dec; 56(6):751-759. PubMed ID: 34732934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.